Evaluation of commercial and automated SARS-CoV-2 IgG and IgA ELISAs using coronavirus disease (COVID-19) patient samples

Antibody-screening methods to detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) need to be validated. We evaluated SARS-CoV-2 IgG and IgA ELISAs in conjunction with the EUROLabworkstation (Euroimmun, Lübeck, Germany). Overall specificities were 91.9% and 73.0% for IgG and IgA ELISA...

全面介紹

Na minha lista:
書目詳細資料
發表在:Euro Surveill
Main Authors: Jääskeläinen, Anne J, Kekäläinen, Eliisa, Kallio-Kokko, Hannimari, Mannonen, Laura, Kortela, Elisa, Vapalahti, Olli, Kurkela, Satu, Lappalainen, Maija
格式: Artigo
語言:Inglês
出版: European Centre for Disease Prevention and Control (ECDC) 2020
主題:
Rapid Communication
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7219034/
https://ncbi.nlm.nih.gov/pubmed/32400364
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2807/1560-7917.ES.2020.25.18.2000603
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍